277 related articles for article (PubMed ID: 22913825)
41. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
42. Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis.
Monteiro AP; Soledade E; Pinheiro CS; Dellatorre-Teixeira L; Oliveira GP; Oliveira MG; Peters-Golden M; Rocco PR; Benjamim CF; Canetti C
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):87-95. PubMed ID: 23947598
[TBL] [Abstract][Full Text] [Related]
43. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: a novel role of the cysteinyl LT-1 receptor.
Wixted JJ; Fanning PJ; Gaur T; O'Connell SL; Silva J; Mason-Savas A; Ayers DC; Stein GS; Lian JB
J Cell Physiol; 2009 Oct; 221(1):31-9. PubMed ID: 19544365
[TBL] [Abstract][Full Text] [Related]
44. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.
Rådmark O; Samuelsson B
Biochem Biophys Res Commun; 2010 May; 396(1):105-10. PubMed ID: 20494120
[TBL] [Abstract][Full Text] [Related]
45. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae.
Mancuso P; Standiford TJ; Marshall T; Peters-Golden M
Infect Immun; 1998 Nov; 66(11):5140-6. PubMed ID: 9784515
[TBL] [Abstract][Full Text] [Related]
46. Leukotriene pathway genetics and pharmacogenetics in allergy.
Duroudier NP; Tulah AS; Sayers I
Allergy; 2009 Jun; 64(6):823-39. PubMed ID: 19416143
[TBL] [Abstract][Full Text] [Related]
47. Leukotrienes as mediators of nasal inflammation.
Knapp HR; Murray JJ
Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():279-88. PubMed ID: 7771342
[TBL] [Abstract][Full Text] [Related]
48. 5-Lipoxygenase: enzyme expression and regulation of activity.
Steinhilber D
Pharm Acta Helv; 1994 Jul; 69(1):3-14. PubMed ID: 7938075
[TBL] [Abstract][Full Text] [Related]
49. Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
Lill AP; Rödl CB; Steinhilber D; Stark H; Hofmann B
Eur J Med Chem; 2015 Jan; 89():503-23. PubMed ID: 25462262
[TBL] [Abstract][Full Text] [Related]
50. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
Nieves D; Moreno JJ
Biochem Pharmacol; 2006 Oct; 72(8):1022-30. PubMed ID: 16934759
[TBL] [Abstract][Full Text] [Related]
51. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
52. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
53. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease.
Rådmark O; Werz O; Steinhilber D; Samuelsson B
Biochim Biophys Acta; 2015 Apr; 1851(4):331-9. PubMed ID: 25152163
[TBL] [Abstract][Full Text] [Related]
54. Pharmacogenetics of the 5-lipoxygenase pathway in asthma.
Silverman E; In KH; Yandava C; Drazen JM
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():164-70; discussion 171-3. PubMed ID: 9988463
[TBL] [Abstract][Full Text] [Related]
55. [Leukotrienes as inflammation mediators].
Woszczek G; Pawliczak R; Kowalski ML
Postepy Hig Med Dosw; 2003; 57(5):593-610. PubMed ID: 14737972
[TBL] [Abstract][Full Text] [Related]
56. Genetics and pharmacogenetics of the leukotriene pathway.
Tantisira KG; Drazen JM
J Allergy Clin Immunol; 2009 Sep; 124(3):422-7. PubMed ID: 19665766
[TBL] [Abstract][Full Text] [Related]
57. Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.
Werz O; Gerstmeier J; Garscha U
Expert Opin Ther Pat; 2017 May; 27(5):607-620. PubMed ID: 28005436
[TBL] [Abstract][Full Text] [Related]
58. Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity.
Alkhamees OA; Alroujayee AS; Abuohashish HM; Alrojayee FS; Ahmed MM
Cancer Chemother Pharmacol; 2017 Jul; 80(1):55-64. PubMed ID: 28502039
[TBL] [Abstract][Full Text] [Related]
59. Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis.
Ago H; Kanaoka Y; Irikura D; Lam BK; Shimamura T; Austen KF; Miyano M
Nature; 2007 Aug; 448(7153):609-12. PubMed ID: 17632548
[TBL] [Abstract][Full Text] [Related]
60. Extending the understanding of leukotrienes in asthma.
Coffey M; Peters-Golden M
Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):57-63. PubMed ID: 12582316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]